Here are six highlights:
1. The clearance included an expandable 20 degree cage as well as more indications for use, such as with allogeneic bone graft and in more spine levels.
2. Surgeons may now use the system in the thoracic spine and at the thoracolumbar junction to treat disc degeneration disease or degenerative spondylolisthesis at one or two adjacent levels.
3. Intended for use during transforaminal lumbar interbody fusion, the TLX system features a low-profile, bulleted design.
4. The system restores sagittal alignment with personalized lordosis degrees.
5. Before this clearance, surgeons could choose among the system’s 15 degree lordotic options. Additionally, the TLX system was only indicated for use with allograft.
6. Surgeons may leverage the TLX interbody system with NuVasive’s Global Alignment software, which helps calculate, correct and confirm pathology.
More articles on devices:
How NICO’s BrainPath Approach & technology is ‘revolutionizing’ neurosurgery
NuVasive, Alphatec, Medtronic & more: 17 device company notes
Stryker receives $3.4M tax rebate to expand in Utah: 5 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
